News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
INOVAIT and DIGITAL Unite to Strengthen Innovation Pathways and Medtech Founder Support
INOVAIT and DIGITAL have signed a MOU to formalize collaboration for accelerating commercialization and strengthening innovation ecosystems.
INOVAIT and the Government of Canada announce the latest recipients of the INOVAIT Pilot Fund for advancements in image-guided therapy and artificial intelligence
INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to announce the latest recipients of its Pilot Fund. This competitive funding program is awarded to compelling medical technology projects that harness the transformative power of AI, machine learning, and big data analytics in IGT to advance medical innovation and streamline care.
INOVAIT announces the release of its impactful new progress report on advancing Canada’s image-guided therapy sector through artificial intelligence
Network News
INOVAIT invests in the Canadian image-guided therapy sector through its Focus Fund
Fund from Sunnybrook-led network will inject up to $22.7 million into the image-guided therapy sector to ultimately deliver better health care to Canadians
Velacur: Providing patients with early detection of liver disease
One in five Canadians have nonalcoholic fatty liver disease (NAFLD), which can...
INOVAIT opens new funding round for image-guided therapy projects
(October 12, 2022 – Toronto, ON) – INOVAIT, the pan-Canadian network supported by the Government of Canada’s Strategic...
INOVAIT announces latest recipients of funding for artificial intelligence and image-guided therapy projects
September 20, 2022 | Toronto, ON – INOVAIT, the pan-Canadian network supported by the Government of Canada’s Strategic...
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media
The Network in the Press
